OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53 | -39.8% | 17,000 | 0.0% | 0.01% | -37.5% |
| Q2 2023 | $88 | -2.2% | 17,000 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $90 | +87.5% | 17,000 | 0.0% | 0.01% | +80.0% |
| Q4 2022 | $48 | -99.9% | 17,000 | 0.0% | 0.01% | -37.5% |
| Q3 2022 | $71,000 | +4.4% | 17,000 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $68,000 | -19.0% | 17,000 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $84,000 | 0.0% | 17,000 | +41.7% | 0.01% | 0.0% |
| Q4 2021 | $84,000 | -89.8% | 12,000 | -90.0% | 0.01% | -90.5% |
| Q3 2018 | $826,000 | +53.0% | 120,001 | +50.0% | 0.08% | +42.4% |
| Q2 2018 | $540,000 | +3.6% | 80,011 | 0.0% | 0.06% | -3.3% |
| Q1 2018 | $521,000 | +46.3% | 80,011 | 0.0% | 0.06% | +45.2% |
| Q4 2017 | $356,000 | – | 80,011 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |